Johnson And Johnson

What do you need to know about the Guillain-Barré disease and Johnson and Johnson vaccines

This is not the first vaccine that has been linked to Guillain-Barré, although the risk appears to be tiny.

COVID-19 Fact Check: What does science say about mixing vaccines?

While the studies show positive results of mixing AstraZeneca and Pfizer, there are still doubts that linger.

Explained: Johnson & Johnson says its COVID-19 vaccine is effective against Delta variant; what this means

J&J has indicated that it is in talks with the Indian government to bring its vaccine to the country of 1.3 billion people

COVID-19 vaccines were developed in under a year, HIV still awaits a vaccine four decades later

Last year, a study in South Africa involved the only vaccine candidate that showed protection, was ultimately not effective enough.

Pfizer, Moderna, Johnson and Johnson vaccines effective against B1617 variant of COVID-19, says top US health official

"The data is coming in, and it looks very encouraging that the US-approved vaccines do have effectiveness against this variant called B1617," Dr Francis Collins, Director of the National Institute of Science said

US to approve Pfizer-BioNTech COVID-19 vaccine for kids aged 12 and above by next week

Moderna and Johnson & Johnson are also conducting trials of its vaccine in teens and younger children as well.

US to resume Johnson & Johnson COVID-19 vaccinations despite rare risk of blood clots

Federal health officials decided that J&J's one-and-done vaccine is critical to fight the pandemic after scientific advisers said its benefits outweigh the risks

India fast-tracks EUA for foreign-produced COVID vaccines amid spike in cases: A look at all the options

The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin

Russia's Sputnik V COVID-19 vaccine gets expert panel nod for emergency use in India

Dr Reddy's conducted the bridge trials in India and will distribute some 100 million doses of the vaccine in India.

Johnson and Johnson expects COVID-19 vaccine results soon but lags behind in production

In 2021, Johnson & Johnson promised to supply 200 million doses to Covax and will supply another 300 million to Covax in 2022.